Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Amortizatization of Intangibles: 2011-2024

Historic Amortizatization of Intangibles for Agios Pharmaceuticals (AGIO) over the last 14 years, with Dec 2024 value amounting to $14.5 million.

  • Agios Pharmaceuticals' Amortizatization of Intangibles fell 2.37% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 27.72%. This contributed to the annual value of $14.5 million for FY2024, which is 35.13% up from last year.
  • As of FY2024, Agios Pharmaceuticals' Amortizatization of Intangibles stood at $14.5 million, which was up 35.13% from $10.7 million recorded in FY2023.
  • Agios Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $14.5 million during FY2024, with a 5-year trough of $9.0 million in FY2020.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $10.7 million (2023), whereas its average is $11.7 million.
  • Data for Agios Pharmaceuticals' Amortizatization of Intangibles shows a peak YoY surged of 35.13% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Agios Pharmaceuticals' Amortizatization of Intangibles stood at $9.0 million in 2020, then increased by 6.18% to $9.5 million in 2021, then grew by 4.80% to $10.0 million in 2022, then grew by 7.25% to $10.7 million in 2023, then surged by 35.13% to $14.5 million in 2024.